Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4174489
Max Phase: Preclinical
Molecular Formula: C22H29NO5
Molecular Weight: 387.48
Molecule Type: Small molecule
Associated Items:
ID: ALA4174489
Max Phase: Preclinical
Molecular Formula: C22H29NO5
Molecular Weight: 387.48
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(C(O)CCN2CCc3cc(OC)c(OC)cc3C2)c(OC)c1
Standard InChI: InChI=1S/C22H29NO5/c1-25-17-5-6-18(20(13-17)26-2)19(24)8-10-23-9-7-15-11-21(27-3)22(28-4)12-16(15)14-23/h5-6,11-13,19,24H,7-10,14H2,1-4H3
Standard InChI Key: NWFHEKGJBBFSSM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 387.48 | Molecular Weight (Monoisotopic): 387.2046 | AlogP: 3.20 | #Rotatable Bonds: 8 |
Polar Surface Area: 60.39 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 7.65 | CX LogP: 2.48 | CX LogD: 2.04 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.75 | Np Likeness Score: -0.22 |
1. Sun YT, Wang GF, Yang YQ, Jin F, Wang Y, Xie XY, Mach RH, Huang YS.. (2018) Synthesis and pharmacological evaluation of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as sigma-2 receptor ligands., 147 [PMID:29438891] [10.1016/j.ejmech.2017.11.016] |
Source(1):